DOI QR코드

DOI QR Code

Determination of Exposure during Handling of 125I Seed Using Thermoluminescent Dosimeter and Monte Carlo Method Based on Computational Phantom

  • Hosein Poorbaygi (Applied Radiation Research School, Nuclear Science and Technology Research Institute) ;
  • Seyed Mostafa Salimi (Departments of Physics, University of Arak-Sardasht Campus) ;
  • Falamarz Torkzadeh (Applied Radiation Research School, Nuclear Science and Technology Research Institute) ;
  • Saeid Hamidi (Departments of Physics, University of Arak-Sardasht Campus) ;
  • Shahab Sheibani (Applied Radiation Research School, Nuclear Science and Technology Research Institute)
  • Received : 2023.07.21
  • Accepted : 2023.10.23
  • Published : 2023.12.31

Abstract

Background: The thermoluminescent dosimeter (TLD) and Monte Carlo (MC) dosimetry are carried out to determine the occupational dose for personnel in the handling of 125I seed sources. Materials and Methods: TLDs were placed in different layers of the Alderson-Rando phantom in the thyroid, lung and also eyes and skin surface. An 125I seed source was prepared and its activity was measured using a dose calibrator and was placed at two distances of 20 and 50 cm from the Alderson-Rando phantom. In addition, the Monte Carlo N-Particle Extended (MCNPX 2.6.0) code and a computational phantom with a lattice-based geometry were used for organ dose calculations. Results and Discussion: The comparison of TLD and MC results in the thyroid and lung is consistent. Although the relative difference of MC dosimetry to TLD for the eyes was between 4% and 13% and for the skin between 19% and 23%, because of the existence of a higher uncertainty regarding TLD positioning in the eye and skin, these inaccuracies can also be acceptable. The isodose distribution was calculated in the cross-section of the head phantom when the 125I seed was at two distances of 20 and 50 cm and it showed that the greatest dose reduction was observed for the eyes, skin, thyroid, and lungs, respectively. The results of MC dosimetry indicated that for near the head positions (distance of 20 cm) the absorbed dose rates for the eye lens, eye and skin were 78.1±2.3, 59.0±1.8, and 10.7±0.7 µGy/mCi/hr, respectively. Furthermore, we found that a 30 cm displacement for the 125I seed reduced the eye and skin doses by at least 3- and 2-fold, respectively. Conclusion: Using a computational phantom to monitor the dose to the sensitive organs (eye and skin) for personnel involved in the handling of 125I seed sources can be an accurate and inexpensive method.

Keywords

Acknowledgement

I need to mention the efforts of our dear colleagues, Mr. Mohammad Reza Javanshir and Reza Naghdi who helped us, build the seed source.

References

  1. Kim JH, Hilaris B. Iodine 125 source in interstitial tumor therapy. Clinical and biological considerations. Am J Roentgenol Radium Ther Nucl Med. 1975;123(1):163-169.  https://doi.org/10.2214/ajr.123.1.163
  2. Shahzadi S, Azimi P, Parsa K. Long-term results of stereotactic brachytherapy (temporary 125iodine seeds) for the treatment of low-grade astrocytoma (grade II). Iran Red Crescent Med J. 2013;15(1):49-57.  https://doi.org/10.5812/ircmj.4322
  3. Ghassemi F, Sheibani S, Arjmand M, Poorbaygi H, Kouhestani E, Sabour S, et al. Comparison of iodide-125 and ruthenium-106 brachytherapy in the treatment of choroidal melanomas. Clin Ophthalmol. 2020;14:339-346.  https://doi.org/10.2147/OPTH.S235265
  4. Cattani F, Vavassori A, Polo A, Rondi E, Cambria R, Orecchia R, et al. Radiation exposure after permanent prostate brachytherapy. Radiother Oncol. 2006;79(1):65-69.  https://doi.org/10.1016/j.radonc.2006.02.010
  5. Anglesio S, Calamia E, Fiandra C, Giglioli FR, Ragona R, Ricardi U, et al. Prostate brachytherapy with iodine-125 seeds: radiation protection issues. Tumori. 2005;91(4):335-338.  https://doi.org/10.1177/030089160509100410
  6. Kaulich TW, Lamprecht U, Paulsen F, Lorenz J, Maurer U, Loeser W, et al. Physikalisch-technische Qualitatssicherung und Strahlenschutz bei der Monotherapie der Prostata mit Jod-125-Seeds [Physical and technical quality assurance and radiation protection in transperineal interstitial permanent prostate brachytherapy with 125-iodine seeds]. Strahlenther Onkol. 2002;178(12):667-675 (German).  https://doi.org/10.1007/s00066-002-0997-5
  7. Fujii K, Ko S, Nako Y, Tonari A, Nishizawa K, Akahane K, et al. Dose measurement for medical staff with glass dosemeters and thermoluminescence dosemeters during 125I brachytherapy for prostate cancer. Radiat Prot Dosimetry. 2011;144(1-4):459-463.  https://doi.org/10.1093/rpd/ncq572
  8. Schiefer H, von Toggenburg F, Seelentag W, Plasswilm L, Ries G, Lenggenhager C, et al. Exposure of treating physician to radiation during prostate brachytherapy using iodine-125 seeds: dose measurements on both hands with thermoluminescence dosimeters. Strahlenther Onkol. 2009;185(10):689-695.  https://doi.org/10.1007/s00066-009-1990-z
  9. Al-Haj AN, Lobriguito AM, Lagarde CS. Radiation dose profile in 125I brachytherapy: an 8-year review. Radiat Prot Dosimetry. 2004;111(1):115-119.  https://doi.org/10.1093/rpd/nch372
  10. Classic KL, Furutani KM, Stafford SL, Pulido JS. Radiation dose to the surgeon during plaque brachytherapy. Retina. 2012;32(9):1900-1905.  https://doi.org/10.1097/IAE.0b013e3182509827
  11. Souza DCB, Rostelato MEC, Vicente R, Zeituni CA, Tiezzi R, Costa OL, et al. Assessment of the risks associated with iodine-125 handling production sources for brachytherapy. 2015 International Nuclear Atlantic Conference (INAC); 2015 Oct 4-9; Sao Paulo, Brazil. Available from: https://inis.iaea.org/collection/NCLCollectionStore/_Public/47/035/47035623.pdf 
  12. International Atomic Energy Agency. Implications for occupational radiation protection of the new dose limit for the lens of the eye: IAEA-TECDOC, no. 1731 [Internet]. IAEA; 2013 [cited 2023 Dec 12]. Available from: https://www-pub.iaea.org/MTCD/Publications/PDF/TE-1731_web.pdf 
  13. Bahruddin NA, Hashim S, Karim MKA, Sabarudin A, Ang WC, Salehhon N, et al. Radiation dose to physicians' eye lens during interventional radiology. J Phys Conf Ser. 2016;694:012035. 
  14. Netherlands Commission on Radiation Dosimetry. Guidelines for radiation protection and dosimetry of the eye lens [Internet]. Netherlands Commission on Radiation Dosimetry; 2018 [cited 2023 Dec 12]. Available from: https://doi.org/10.25030/ncs-031 
  15. International Organization of Standardization. ISO 15382: Radiological protection: procedures for monitoring the dose to the lens of the eye, the skin and the extremities. ISO; 2015. 
  16. International Radiation Protection Association. IRPA guidance on implementation of eye dose monitoring and eye protection of workers [Internet]. IRPA; 2017 [cited 2023 Dec 12]. Available from: https://www.irpa.net/docs/IRPA%20Guidance%20on%20Implementation%20of%20Eye%20Dose%20Monitoring%20(2017).pdf 
  17. Wang B, Xu XG, Bozkurt A, Goorley JT. Issues related to the use of MCNP code for an extremely large voxel model VIP-Man. American Nuclear Society Topical Mitting in Monte Carlo; 2005 Apr 17-21; Chattanooga, TN, USA. 
  18. Lohrabian V, Sheibani S, Aghamiri MR, Ghozati B, Poorbaygi H, Baghani HR. Determination of dosimetric characteristics of IrSeed 125I brachytherapy source. Iran J Med Phys. 2013;10(2):109-117. 
  19. Sheikholeslami S, Nedaie HA, Sadeghi M, Pourbeigy H, Shahzadi S, Zehtabian M, et al. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source. J Appl Clin Med Phys. 2016;17(4):430-441.  https://doi.org/10.1120/jacmp.v17i4.6127
  20. Carrillo RE, Uribe RM, Woodruff GL, Stoebe TG. Lithium fluoride (TLD-700) response to a mixed thermal neutron and gamma field. Radiat Prot Dosimetry. 1987;19(1):55-57. 
  21. Meigooni AS, Mishra V, Panth H, Williamson J. Instrumentation and dosimeter-size artifacts in quantitative thermoluminescence dosimetry of low-dose fields. Med Phys. 1995;22(5):555-561.  https://doi.org/10.1118/1.597555
  22. Xu XG. An exponential growth of computational phantom research in radiation protection, imaging, and radiotherapy: a review of the fifty-year history. Phys Med Biol. 2014;59(18):R233-R302.  https://doi.org/10.1088/0031-9155/59/18/R233
  23. James MR, McKinney GW, Durkee JW, Fensin ML, Hendricks JS, Pelowitz DB, et al. MCNPX 2.7.X: New features being developed LA-UR-09-6788. 2009 IEEE/NSS Conference; 2009 Oct 25-31; Orlando, FL, USA. p. 25-31. 
  24. Martin CJ, Magee JS, Sandblom V, Almen A, Lundh C. Eye dosimetry and protective eyewear for interventional clinicians. Radiat Prot Dosimetry. 2015;165(1-4):284-288. https://doi.org/10.1093/rpd/ncv050